Paper · 41543151

Role of tumor‑infiltrating lymphocytes and miR‑155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review).

Alvares-Vilela MM and 4 others. Oncol Rep, 2026. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Role of tumor‑infiltrating lymphocytes and miR‑155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review). Papers, record 41543151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41543151

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Role of tumor‑infiltrating lymphocytes and miR‑155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review).; PubMed
Journal: Oncol Rep; PubMed
Year: 2026; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/41543151/; PubMed
DOI: https://doi.org/10.3892/or.2026.9047; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC12828645/; PubMed
The journal: https://conductscience.org/library/journal-index/9422756; PubMed
Citations, by iCite: 2; iCite
Revised in PubMed: 2026-09-26; PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Alvares-Vilela MM	Miriam Monteiro
2	Schlemmer F	Franciele
3	Ferrari SSAR	Sabrina Simplício De Araújo Romero
4	Xavier ME	Mary-Ann Elvina
5	Titze-De-Almeida R	Ricardo

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
MicroRNAs	Major topic
Lymphocytes, Tumor-Infiltrating	Major topic
Biomarkers, Tumor	Major topic
Breast Neoplasms	Major topic
Triple Negative Breast Neoplasms	Major topic
Humans
Female
Prognosis
Tumor Microenvironment
Gene Expression Regulation, Neoplastic
Carcinogenesis

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References216

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	32,823,863	Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review.	Int J Mol Sci	2020	https://conductscience.org/library/papers/32823863	PubMed
2	25,214,542	The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.	Ann Oncol	2015	https://conductscience.org/library/papers/25214542	PubMed
3	22,927,033	Circulating microRNAs in plasma as early detection markers for breast cancer.	Int J Cancer	2013	https://conductscience.org/library/papers/22927033	PubMed
4	25,524,383	Current advances in T-cell-based cancer immunotherapy.	Immunotherapy	2014	https://conductscience.org/library/papers/25524383	PubMed
5	19,239,886	Origins and Mechanisms of miRNAs and siRNAs.	Cell	2009	https://conductscience.org/library/papers/19239886	PubMed
6	34,072,348	MicroRNA Therapeutics in Cancer: Current Advances and Challenges.	Cancers (Basel)	2021	https://conductscience.org/library/papers/34072348	PubMed
7	31,927,455	Triple negative breast cancer: A thorough review of biomarkers.	Crit Rev Oncol Hematol	2020	https://conductscience.org/library/papers/31927455	PubMed
8	32,968,446	Circulating microRNAs and their role in the immune response in triple-negative breast cancer.	Oncol Lett	2020	https://conductscience.org/library/papers/32968446	PubMed
9	16,103,053	MicroRNA gene expression deregulation in human breast cancer.	Cancer Res	2005	https://conductscience.org/library/papers/16103053	PubMed
10	20,148,675	Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics.	Annu Rev Physiol	2010	https://conductscience.org/library/papers/20148675	PubMed

1 to 10 of 216

See all 216 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMID	Title	Journal	Year	In Papers	Source
42,794,522	miR-155 Directly Targets MARCH7 and Modulates Viability and Invasive Phenotypes in Breast Cancer Cells.	Int J Mol Sci	2026	https://conductscience.org/library/papers/42794522	PubMed
42,249,487	Comparative study of the tumor-infiltrating lymphocytes before and after neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.	J Cardiothorac Surg	2026	https://conductscience.org/library/papers/42249487	PubMed

Genes75

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
AGO2	27,161	PubTator's text mining	https://conductscience.org/library/genes/27161	NCBI Gene
AKT1	207	PubTator's text mining	https://conductscience.org/library/genes/207	NCBI Gene
BCL2	596	PubTator's text mining	https://conductscience.org/library/genes/596	NCBI Gene
BRCA1	672	PubTator's text mining	https://conductscience.org/library/genes/672	NCBI Gene
BTLA	151,888	PubTator's text mining	https://conductscience.org/library/genes/151888	NCBI Gene
CCL5	6,352	PubTator's text mining	https://conductscience.org/library/genes/6352	NCBI Gene
CD274	29,126	PubTator's text mining	https://conductscience.org/library/genes/29126	NCBI Gene
CD28	940	PubTator's text mining	https://conductscience.org/library/genes/940	NCBI Gene
CD4	920	PubTator's text mining	https://conductscience.org/library/genes/920	NCBI Gene
CD40	958	PubTator's text mining	https://conductscience.org/library/genes/958	NCBI Gene

1 to 10 of 75

See all 75 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41543151

GET https://conductscience.org/api/papers/v1/41543151/references?page=2

API reference For AI assistants